Table I.

Demographic and clinical characteristics in subjects with CRSwNP and dysosmia (such as anosmia or hyposmia) or normosmia.

Variable	Dysosmia (n = 55)	Normosmia (n = 7)	P value
Male gender	22 (40.00%)	3 (42.86%)	1.00#
Age [years, mean (SD)]	50.25 (14.66)	47.43 (15.20)	0.63
Nasal polyposis
Grade 1	15 (27.27%)	2 (28.57%)	0.76#
Grade 2	13 (23.64%)	3 (42.86%)
Grade 3	20 (36.36%)	2 (28.57%)
Grade 4	7 (12.73%)	0
Allergy	38 (69.09%)	3 (42.86%)	0.21#
Asthma	22 (40.00%)	1 (14.29%)	0.24#
ASA sensitivity	7 (12.73%)	0	1.00#
Asthma + ASA sensitivity	5 (18.52%)	0	0.36#
Nasal neutrophils	4 (7.27%)	5 (71.43%)	0.0004#
Nasal eosinophils	50 (90.91%)	1 (14.29%)	< 0.0001#
Mast cells	25 (45.45%)	1 (14.29%)	0.22#
Cytotypes
Neutrophils	4 (7.27%)	5 (71.43%)	< 0.0001#
Eosinophils	26 (47.27%)	1 (14.29%)
Mast cells	1 (1.82%)	1 (14.29%)
Eosinophils + mast cells	24 (43.64%)	0
CCG [mean (SD)]	5.84 (2.20)	2.86 (2.48)	0.0015
CCG score
Low (≤ 3)	5 (9.09%)	4 (57.14%)	0.012#
Medium (4-6)	26 (47.27%)	2 (28.57%)
High (≥ 7)	24 (43.64%)	1 (14.29%)

All variables are reported as absolute frequency and percentage in parentheses unless otherwise specified.

#: Fisher exact test; ASA: Acetylsalicylic acid; CCG: clinical-cytological grading.